131 related articles for article (PubMed ID: 6085754)
1. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
Avramis VI; Plunkett W
Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
Avramis VI
Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
[TBL] [Abstract][Full Text] [Related]
3. 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
Avramis VI; Plunkett W
Biochem Biophys Res Commun; 1983 May; 113(1):35-43. PubMed ID: 6860342
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
5. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
Noker PE; Duncan GF; El Dareer SM; Hill DL
Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
[TBL] [Abstract][Full Text] [Related]
6. 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
Danhauser L; Plunkett W; Keating M; Cabanillas F
Cancer Chemother Pharmacol; 1986; 18(2):145-52. PubMed ID: 2431803
[TBL] [Abstract][Full Text] [Related]
7. Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity.
Huang P; Chubb S; Plunkett W
J Biol Chem; 1990 Sep; 265(27):16617-25. PubMed ID: 1697861
[TBL] [Abstract][Full Text] [Related]
8. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
Riva CM; Rustum YM
Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
[TBL] [Abstract][Full Text] [Related]
9. Phosphorolytic cleavage of 2-fluoroadenine from 9-beta-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. A pathway for 2-fluoro-ATP production.
Huang P; Plunkett W
Biochem Pharmacol; 1987 Sep; 36(18):2945-50. PubMed ID: 3307790
[TBL] [Abstract][Full Text] [Related]
10. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
Struck RF; Shortnacy AT; Kirk MC; Thorpe MC; Brockman RW; Hill DL; El Dareer SM; Montgomery JA
Biochem Pharmacol; 1982 Jun; 31(11):1975-8. PubMed ID: 7115418
[TBL] [Abstract][Full Text] [Related]
11. Interaction of arabinosyl nucleotides in K562 human leukemia cells.
Gandhi V; Plunkett W
Biochem Pharmacol; 1989 Oct; 38(20):3551-8. PubMed ID: 2479383
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
Gandhi V; Plunkett W
Cancer Chemother Pharmacol; 1992; 31(1):11-7. PubMed ID: 1458554
[TBL] [Abstract][Full Text] [Related]
13. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition.
Catapano CV; Perrino FW; Fernandes DJ
J Biol Chem; 1993 Apr; 268(10):7179-85. PubMed ID: 7681821
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 9-[5'-(2-oxo-1,3,2-oxazaphosphorinan-2-yl)-beta-D-arabinosyl]ade nine and 9-[5'-(2-oxo-1,3,2-dioxaphosphorinan-2-yl)-beta-D-arabinosyl]ade nine: potential neutral precursors of 9-[beta-D-arabinofuranosyl]adenine 5'-monophosphate.
Farquhar D; Smith R
J Med Chem; 1985 Sep; 28(9):1358-61. PubMed ID: 2411927
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
[TBL] [Abstract][Full Text] [Related]
16. The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage.
Sampath D; Plunkett W
Cancer Res; 2000 Nov; 60(22):6408-15. PubMed ID: 11103806
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA synthesis in permeabilized mouse P815 mast cells by arabinofuranosyladenine 5'-triphosphate.
Geurtsen W; Zahn RK; Maidhof A; Schmidseder R; Müller WE
Chemotherapy; 1981; 27(1):61-7. PubMed ID: 6163594
[TBL] [Abstract][Full Text] [Related]
18. Cellular and clinical pharmacology of fludarabine.
Gandhi V; Plunkett W
Clin Pharmacokinet; 2002; 41(2):93-103. PubMed ID: 11888330
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
[TBL] [Abstract][Full Text] [Related]
20. A 3'-5' exonuclease in human leukemia cells: implications for resistance to 1-beta -D-arabinofuranosylcytosine and 9-beta -D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate.
Skalski V; Brown KR; Choi BY; Lin ZY; Chen S
J Biol Chem; 2000 Aug; 275(33):25814-9. PubMed ID: 10833512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
